Biotech News
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
Oramed Pharmaceuticals Inc. has announced the formation of a new joint venture, OraTech Pharmaceuticals Inc., to advance its Protein Oral Delivery (POD) technology. The agreement, made in partnership with Hefei Tianhui Biotech Co., Ltd. (HTIT), is structured to accelerate the
12 February 2025
Stay ahead of trends and best practices
